These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 15806158

  • 1. Distinct molecular phenotype of malignant CD34(+) hematopoietic stem and progenitor cells in chronic myelogenous leukemia.
    Kronenwett R, Butterweck U, Steidl U, Kliszewski S, Neumann F, Bork S, Blanco ED, Roes N, Gräf T, Brors B, Eils R, Maercker C, Kobbe G, Gattermann N, Haas R.
    Oncogene; 2005 Aug 11; 24(34):5313-24. PubMed ID: 15806158
    [Abstract] [Full Text] [Related]

  • 2. Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells.
    Veena P, Cornetta K, Davidson A, Agüero B, McMahel J, Traycoff CM, Srour EF.
    Bone Marrow Transplant; 1997 Jun 11; 19(12):1213-21. PubMed ID: 9208115
    [Abstract] [Full Text] [Related]

  • 3. Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase.
    Diaz-Blanco E, Bruns I, Neumann F, Fischer JC, Graef T, Rosskopf M, Brors B, Pechtel S, Bork S, Koch A, Baer A, Rohr UP, Kobbe G, von Haeseler A, Gattermann N, Haas R, Kronenwett R.
    Leukemia; 2007 Mar 11; 21(3):494-504. PubMed ID: 17252012
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
    Engelhardt M, Mackenzie K, Drullinsky P, Silver RT, Moore MA.
    Cancer Res; 2000 Feb 01; 60(3):610-7. PubMed ID: 10676644
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
    Bruns I, Steidl U, Fischer JC, Czibere A, Kobbe G, Raschke S, Singh R, Fenk R, Rosskopf M, Pechtel S, von Haeseler A, Wernet P, Tenen DG, Haas R, Kronenwett R.
    Haematologica; 2008 Mar 01; 93(3):347-55. PubMed ID: 18268278
    [Abstract] [Full Text] [Related]

  • 9. Human stem cell model to study signal transduction and molecular regulation mechanisms in CML.
    Fan E, Hu Y, Zhao C.
    Chin Med J (Engl); 2001 Jul 01; 114(7):680-4. PubMed ID: 11780326
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. L-selectin expression is low on CD34+ cells from patients with chronic myeloid leukemia and interferon-a up-regulates this expression.
    Martín-Henao GA, Quiroga R, Sureda A, González JR, Moreno V, García J.
    Haematologica; 2000 Feb 01; 85(2):139-46. PubMed ID: 10681720
    [Abstract] [Full Text] [Related]

  • 15. Initial expression of interferon alpha receptor 2 (IFNAR2) on CD34-positive cells and its down-regulation correlate with clinical response to interferon therapy in chronic myelogenous leukemia.
    Ito K, Tanaka H, Ito T, Sultana TA, Kyo T, Imanaka F, Ohmoto Y, Kimura A.
    Eur J Haematol; 2004 Sep 01; 73(3):191-205. PubMed ID: 15287917
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Upregulation of the TGFbeta signalling pathway by Bcr-Abl: implications for haemopoietic cell growth and chronic myeloid leukaemia.
    Møller GM, Frost V, Melo JV, Chantry A.
    FEBS Lett; 2007 Apr 03; 581(7):1329-34. PubMed ID: 17349636
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Protein tyrosine phosphatase receptor type {gamma} is a functional tumor suppressor gene specifically downregulated in chronic myeloid leukemia.
    Della Peruta M, Martinelli G, Moratti E, Pintani D, Vezzalini M, Mafficini A, Grafone T, Iacobucci I, Soverini S, Murineddu M, Vinante F, Tecchio C, Piras G, Gabbas A, Monne M, Sorio C.
    Cancer Res; 2010 Nov 01; 70(21):8896-906. PubMed ID: 20959494
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.